RxDB
ICD-10-CM Codes Browse (Tabular) Diagnostic External Drug Neoplasm

T49.4X6S – Underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela

Overview

Coding Notes

Active
Billable, valid for HIPAA-covered transactions

GEM Conversion to ICD-9 CM

Fs: 11000

MDC / MS-DRG Reference

AFTERCARE WITH CC/MCC
AFTERCARE WITHOUT CC/MCC

Sibling Codes

Underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter
Underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter

Parent Sibling Codes

Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, accidental (unintentional)
Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, intentional self-harm
Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, assault
Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, undetermined
Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations
Underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations

Codes with Same Suffix

Epidural hemorrhage with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela
Underdosing of tetracyclines, sequela
Underdosing of anthelminthics, sequela
Underdosing of oral contraceptives, sequela
Underdosing of antirheumatics, not elsewhere classified, sequela
Underdosing of other synthetic narcotics, sequela
Underdosing of benzodiazepines, sequela
Underdosing of butyrophenone and thiothixene neuroleptics, sequela
Underdosing of predominantly alpha-adrenoreceptor agonists, sequela
Underdosing of iron and its compounds, sequela
Underdosing of angiotensin-converting-enzyme inhibitors, sequela
Underdosing of other laxatives, sequela
Underdosing of expectorants, sequela
Underdosing of drugs affecting uric acid metabolism, sequela